As of December 2025 I-Mab Biopharma has a market cap of NZ$0.92 Billion. This makes I-Mab Biopharma the world's 7045th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.